Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
Olga Furman, Alisa Zaporozhets, Dror Tobi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1505-1505
Open Access | Times Cited: 19

Showing 19 citing articles:

20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
Satyam Singh, Sushabhan Sadhukhan, Avinash Sonawane
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188967-188967
Closed Access | Times Cited: 37
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 11
Mechanism of Peptide Self-assembly and Its Study in Biomedicine
Xinyue Yang, Li Ma, Kui Lü, et al.
The Protein Journal (2024) Vol. 43, Iss. 3, pp. 464-476
Closed Access | Times Cited: 6
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges
Monireh Esmaeili Rad, Caner Soylukan, Prabir Kumar Kulabhusan, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 48, pp. 55201-55231
Closed Access | Times Cited: 11
Selecting Peptides for Targeted Delivery of Drugs Inside Cancer Cells
Kalimuthu Kalishwaralal, Abhishek Singh, Sachin Sharma, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access
Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer
Poulami Sarkar, M. Rizwan Sardar, Olivia Sen, et al.
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access | Times Cited: 2
A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysis
Xiaoxu Li, Ximing Pu, Xingming Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123306-123306
Closed Access | Times Cited: 5
Design and investigation of interactions of novel peptide conjugates of purine and pyrimidine derivatives with EGFR and its mutant T790M/L858R: an in silico and laboratory study
Hannah L. Hunt, Beatriz G. Goncalves, Mary A. Biggs, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach
Ali Kaynar, Mehmet Özcan, Xiangyu Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7868-7868
Open Access | Times Cited: 1
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
Cibele Rodrigues Toledo, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8553-8553
Open Access | Times Cited: 1
Using NGS to Uncover the Corruption of a Peptide Phage Display Selection
Danna Kamstrup Sell, Babak Bakhshinejad, Anders Wilgaard Sinkjær, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10590-10605
Open Access | Times Cited: 1
Development and Challenges of Cyclic Peptides for Immunomodulation
Xianqiong Jiang, Li Gao, Zhilong Li, et al.
Current Protein and Peptide Science (2023) Vol. 25, Iss. 5, pp. 353-375
Closed Access | Times Cited: 2
Nuclear Rac1 controls nuclear architecture and cell migration of glioma cells
Natalia Nowak, Hanna Sas-Nowosielska, Jędrzej Szymański
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 7, pp. 130632-130632
Closed Access
A war on many fronts: cross disciplinary approaches for novel cancer treatment strategies
Adriana Del Pino Herrera, Meghan C. Ferrall‐Fairbanks
Frontiers in Genetics (2024) Vol. 15
Open Access
Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer
Andrii Bazylevich, Anthony R. Miller, Irina G. Tkachenko, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1613-1613
Open Access
HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study
Nazende Nur Bayram, Gizem Tuğçe Ulu, Nusaibah Abdulsalam Abdulhadi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 733-733
Open Access | Times Cited: 1
Methods for Engineering Binders to Multi-Pass Membrane Proteins
Benjamin Thomas, Karuppiah Chockalingam, Zhilei Chen
Bioengineering (2023) Vol. 10, Iss. 12, pp. 1351-1351
Open Access | Times Cited: 1
Computational Design, Combinatorial Screening and Experimental Analysis of Lung Cancer EGFRVIII-Binding Peptides
Dongyun Gao, Jun Yao, Xuefeng Zhou, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 175-188
Closed Access
Page 1

Scroll to top